Bill Sponsor
House Bill 2630
117th Congress(2021-2022)
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Became Law
Became Law
Became Public Law 117-12 on May 4, 2021
Overview
Text
Introduced
Apr 16, 2021
Latest Action
Oct 19, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2630
Congress
117
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Sponsorship by Party
Democrat
New Hampshire
Democrat
New Jersey
House Votes (1)
Senate Votes (1)
checkPassed on April 21, 2021
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2025)
Summary

Extending Temporary Emergency Scheduling of Fentanyl Analogues Act

This bill extends until September 30, 2021, the temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances in schedule I of the Controlled Substances Act. The temporary order expires on May 6, 2021.

Text (4)
Actions (18)
10/19/2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
05/04/2021
Became Public Law No: 117-12.
05/04/2021
Signed by President.
04/30/2021
Presented to President.
04/29/2021
Message on Senate action sent to the House.
04/29/2021
Passed Senate without amendment by Voice Vote. (consideration: CR S2323-2324)
04/29/2021
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S2323-2324)
04/22/2021
Received in the Senate, read twice.
04/21/2021
The title of the measure was amended. Agreed to without objection.
04/21/2021
Motion to reconsider laid on the table Agreed to without objection.
04/21/2021
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2025)
04/21/2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2025)
04/21/2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2630.
04/21/2021
Considered under suspension of the rules. (consideration: CR H2025-2029)
04/21/2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
04/19/2021
Referred to the Subcommittee on Health.
04/16/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/16/2021
Introduced in House
Public Record
Record Updated
Mar 8, 2023 7:58:48 PM